- Home
- NVT vs PEN Comparison
NVT vs PEN Comparison
Compare NVT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVT | PEN |
|---|---|---|
| Founded | 1903 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.1B | 10.9B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | NVT | PEN |
|---|---|---|
| Price | $107.76 | $300.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 16 |
| Target Price | $107.58 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 2.2M | 479.9K |
| Earning Date | 10-31-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | 6.36 | ★ 367.34 |
| EPS | 3.64 | ★ 4.14 |
| Revenue | ★ $3,578,600,000.00 | $1,333,798,000.00 |
| Revenue This Year | $28.70 | $16.77 |
| Revenue Next Year | $14.60 | $14.12 |
| P/E Ratio | ★ $60.23 | $72.65 |
| Revenue Growth | ★ 21.54 | 14.61 |
| 52 Week Low | $41.71 | $221.26 |
| 52 Week High | $117.52 | $310.00 |
Technical Indicators
Market Signals| Indicator | NVT | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 54.94 | 67.77 |
| Support Level | $102.25 | $284.95 |
| Resistance Level | $108.89 | $298.69 |
| Average True Range (ATR) | 3.74 | 8.02 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 76.57 | 91.50 |
Price Performance
Historical ComparisonAbout NVT nVent Electric plc
NVent is a leading global provider of electrical connection and protection solutions that touch a broad range of end markets, including infrastructure, industrial, commercial, and residential. NVent designs, manufactures, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.